 Connection
Marc Bonaca to Aminobutyrates
This is a "connection" page, showing publications Marc Bonaca has written about Aminobutyrates.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.454 |
|
|
|
-
Martins EB, Madrini V, Ramos Souza PV, Tavares CAM, Albuquerque MT, Santo KE, Harrington JA, Canonico ME, El Rafei A, Bonaca MP, Guimaraes PO. ANSWER-HF: sacubitril-valsartan reduces NT-proBNP in heart failure due to Chagas cardiomyopathy despite no reverse remodeling. Heart Fail Rev. 2026 03 23; 31(1).
Score: 0.236
-
Saldarriaga CI, Zannad F, McMullan CJ, Xing A, Gates D, Anstrom KJ, Bonaca MP, Corda S, Ezekowitz JA, Lam CSP, Lewis EF, Lindenfeld J, Mentz RJ, O'Connor C, Patel M, Ponikowski P, Reddy YNV, Rosano GMC, Senni M, Udelson J, Voors AA, Butler J. Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial. Eur J Heart Fail. 2025 Aug; 27(8):1426-1435.
Score: 0.218
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|